[EN] PHARMACEUTICAL COMPOSITION CONTAINING RILIGUSTILIDE AND USE THEREOF<br/>[FR] COMPOSITION PHARMACEUTIQUE CONTENANT DU RILIGUSTILIDE ET UTILISATION ASSOCIÉE
申请人:SHENYANG BLUESONG BIOMEDICINAL TECHNOLOGY CO LTD
Two pairs of enantiomeric phthalide trimers [(-)/(+) triligustilides A (1a/1b) and (-)/(+) triligustilides B (2a/2b)] with complex polycyclic skeletons simultaneously possessing bridged, fused, and spiro ring systems were isolated from Angelica sinensis, together with two pairs of new phthalide dimers. The biogenetic pathways of new phthalides were proposed, and their bioactivities were also evaluated. This is the first time optically pure polymeric phthalides have been obtained from racemates, and their absolute configurations are reported.
JPH07233060A
申请人:——
公开号:JPH07233060A
公开(公告)日:1995-09-05
Use of Phthalide Derivatives
申请人:Chen Fei
公开号:US20080255061A1
公开(公告)日:2008-10-16
Disclosed a class of phthalide derivatives and the use of which to manufacture the sensitizer or reverser of the antineoplastic agent. The phthalide derivatives according to the invention can enhance the sensitivity of drug-resistance tumor cells against chemotherapy and decrease the drug-resistance of tumor cells 5-30 folder and enhance notably several chemotherapy agents-induced apoptosis of tumor cells